Spots Global Cancer Trial Database for nasopharyngeal cancer
Every month we try and update this database with for nasopharyngeal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study | NCT04995185 | Nasopharyngeal ... | (18)F-fluoromis... | 21 Years - 99 Years | National Cancer Centre, Singapore | |
| Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer | NCT02875613 | Nasopharyngeal ... | Avelumab | 18 Years - | University of California, San Diego | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy | NCT01937793 | Nasopharyngeal ... Dysphagia | effortful swall... Mendelsohn swal... | 20 Years - 70 Years | National Taiwan University Hospital | |
| Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | NCT00078494 | Nasopharyngeal ... | EBV-LMP-2 | - | National Institutes of Health Clinical Center (CC) | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Reactivating NK Cells in Treating Refractory Head and Neck Cancer | NCT02507154 | Nasopharyngeal ... Head and Neck S... | Cetuximab + NK ... | 21 Years - | National University Hospital, Singapore | |
| Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment | NCT04875611 | Nasopharyngeal ... | Opdivo | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | NCT04004871 | Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Can... | Nab-paclitaxel,... concurrent chem... | 18 Years - 60 Years | Guangxi Medical University | |
| Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) | NCT03682055 | Nasopharyngeal ... Nasopharyngeal ... | VK-2019 | 18 Years - | Cullinan Therapeutics Inc. | |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | NCT00790569 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | nicotine varenicline placebo | 18 Years - 120 Years | Butler Hospital | |
| Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma | NCT04453826 | Nasopharyngeal ... Chemotherapy Radiotherapy PD-1 Therapy | Camrelizumab pl... Chemo-radiother... | 18 Years - 70 Years | Sun Yat-sen University | |
| Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer | NCT00623129 | Head and Neck C... Radiation Toxic... Xerostomia | questionnaire a... electroacupunct... management of t... quality-of-life... | 21 Years - 89 Years | Mayo Clinic | |
| Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT | NCT05628922 | Nasopharyngeal ... | Toripalimab Induction chemo... | 18 Years - 70 Years | Fudan University | |
| Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) | NCT03769467 | Nasopharyngeal ... Nasopharyngeal ... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... | tabelecleucel pembrolizumab | 12 Years - | Atara Biotherapeutics | |
| Testing Accountability in Patient Adherence | NCT01844557 | Head And Neck C... | Swallowing Exer... Symptom Invento... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00003489 | Head and Neck C... | Antineoplaston ... | 16 Years - 99 Years | Burzynski Research Institute | |
| Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy | NCT01094405 | Nasopharyngeal ... Epstein-Barr Vi... | Recombinant Eps... | 18 Years - | Chinese University of Hong Kong | |
| Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia | NCT02292368 | Head and Neck C... | Questionnaires Acupuncture Electroencephal... | 18 Years - | M.D. Anderson Cancer Center | |
| Bevacizumab and Pembrolizumab Combination in EBER-ISH Positive NPC | NCT03813394 | Locally Recurre... Metastatic Naso... | pembrolizumab bevacizumab | 21 Years - 99 Years | National University Hospital, Singapore | |
| A Study of Nasopharyngeal Carcinoma From Guangdong | NCT03003182 | Nasopharyngeal ... | - | Sun Yat-sen University | ||
| A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors | NCT04476641 | Liver Cancer Kidney Cancer Nasopharyngeal ... Lung Cancer Colorectal Canc... Breast Cancer | CELL | 18 Years - 75 Years | Sun Yat-sen University | |
| A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. | NCT00439426 | Nasopharyngeal ... | Oxaliplatin capecitabine [X... | 18 Years - 75 Years | Hoffmann-La Roche | |
| Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure | NCT00530049 | Head and Neck C... Psychosocial Ef... | questionnaire a... assessment of t... psychosocial as... quality-of-life... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma | NCT06268600 | Nasopharyngeal ... Nasopharyngeal ... Hypothyroidism | Modified neck t... | 18 Years - 75 Years | Jiangxi Provincial Cancer Hospital | |
| Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | NCT00141765 | Wilms Tumor Fibrosarcoma Carcinoma, Roun... Nasopharyngeal ... Brain Tumor, Re... | Myeloablative C... Stem Cell Rescu... | - 21 Years | University of Michigan Rogel Cancer Center | |
| Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use | NCT00799669 | Head and Neck C... Tobacco Use Dis... | smoking cessati... counseling inte... preventive inte... questionnaire a... | 18 Years - | M.D. Anderson Cancer Center | |
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | NCT04340024 | Nasopharyngeal ... Prostate Cancer Other Cancer | 21 Years - 99 Years | National Cancer Centre, Singapore | ||
| Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | NCT00078494 | Nasopharyngeal ... | EBV-LMP-2 | - | National Institutes of Health Clinical Center (CC) | |
| Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) | NCT03682055 | Nasopharyngeal ... Nasopharyngeal ... | VK-2019 | 18 Years - | Cullinan Therapeutics Inc. | |
| Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers | NCT00900419 | Esophageal Canc... Head and Neck C... Lung Cancer Precancerous Co... | immunohistochem... laboratory biom... sputum cytology biopsy | 21 Years - 90 Years | University of Colorado, Denver | |
| An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies | NCT03144661 | Hepatocellular ... Cholangiocarcin... Esophageal Canc... Nasopharyngeal ... Ovarian Cancer Solid Tumors | INCB062079 | 18 Years - | Incyte Corporation | |
| Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer | NCT00656513 | Head and Neck C... Xerostomia | Pilocarpine ALTENS | 18 Years - | Radiation Therapy Oncology Group | |
| Phase II Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer | NCT05305131 | Nasopharyngeal ... | cisplatin and g... induction chemo... | 21 Months - 99 Years | National University Hospital, Singapore | |
| P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | NCT05239143 | Breast Cancer Ovarian Cancer Non Small Cell ... Colorectal Canc... Pancreatic Canc... Renal Cell Carc... Nasopharyngeal ... Head and Neck S... Gastric Cancer | P-MUC1C-ALLO1 C... Rimiducid | 18 Years - | Poseida Therapeutics, Inc. | |
| Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions | NCT03129412 | Nasopharyngeal ... Neoplasm Metast... | radical radioth... | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
| Adebrelimab and Chemoradiotherapy in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma | NCT06349889 | Nasopharyngeal ... Nasopharyngeal ... | Adebrelimab | 18 Years - 65 Years | Sun Yat-sen University | |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00003489 | Head and Neck C... | Antineoplaston ... | 16 Years - 99 Years | Burzynski Research Institute | |
| Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer | NCT05564286 | Cervical Cancer Nasopharyngeal ... Chemotherapy-in... Radiation-Induc... Antiemetic | Fosaprepitant tropisetron Dexamethasone | 18 Years - 75 Years | Shantou University Medical College | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | NCT00101335 | Head and Neck C... Precancerous Co... | celecoxib | 18 Years - | Fox Chase Cancer Center | |
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | NCT05638269 | Essential Hyper... Liver Cancer Nasopharyngeal ... Pancreatic Canc... Lung Cancer Chronic Kidney ... Acute Coronary ... Epilepsy Gastric Cancer Primary Aldoste... Subclinical hyp... | no intervention | 18 Years - 75 Years | Zhujiang Hospital | |
| A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors | NCT05592626 | Advanced Solid ... Genital Neoplas... Urogenital Neop... Lung Neoplasm Neoplasms by Si... Papillomavirus ... Epstein-Barr Vi... Carcinoma Neoplasms Vulvar Neoplasm... Vulvar Diseases Abdominal Neopl... | STAR0602 | 18 Years - | Marengo Therapeutics, Inc. | |
| Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
| Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer | NCT02875613 | Nasopharyngeal ... | Avelumab | 18 Years - | University of California, San Diego | |
| Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer | NCT01312311 | Nasopharyngeal ... | Docetaxel, Cisp... | 18 Years - | Samsung Medical Center | |
| A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy | NCT00370890 | Nasopharyngeal ... | Adjuvant chemot... | 18 Years - | Chinese University of Hong Kong | |
| Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | NCT00666978 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | smoking cessati... bupropion hydro... gene expression... polymerase chai... counseling inte... educational int... psychosocial as... | 18 Years - | University of Kansas Medical Center | |
| Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy | NCT06414577 | Nasopharyngeal ... | Irinotecan Lipo... | 18 Years - | Sun Yat-sen University | |
| Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT | NCT05628922 | Nasopharyngeal ... | Toripalimab Induction chemo... | 18 Years - 70 Years | Fudan University | |
| Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia | NCT00052611 | Head and Neck C... | Celecoxib | 18 Years - | Dana-Farber Cancer Institute | |
| Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations | NCT00070785 | Epstein-Barr Vi... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | NCT05239143 | Breast Cancer Ovarian Cancer Non Small Cell ... Colorectal Canc... Pancreatic Canc... Renal Cell Carc... Nasopharyngeal ... Head and Neck S... Gastric Cancer | P-MUC1C-ALLO1 C... Rimiducid | 18 Years - | Poseida Therapeutics, Inc. | |
| Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation | NCT05101889 | Oral Mucositis | Oral Impact® | 18 Years - 65 Years | Prince of Songkla University | |
| An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies | NCT03144661 | Hepatocellular ... Cholangiocarcin... Esophageal Canc... Nasopharyngeal ... Ovarian Cancer Solid Tumors | INCB062079 | 18 Years - | Incyte Corporation | |
| Bupropion in Helping Adults Stop Smoking | NCT00534001 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | bupropion hydro... placebo | 18 Years - 65 Years | Roswell Park Cancer Institute | |
| Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients | NCT00304694 | Nasopharyngeal ... | 18 Years - 80 Years | National Taiwan University Hospital | ||
| Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | NCT00101335 | Head and Neck C... Precancerous Co... | celecoxib | 18 Years - | Fox Chase Cancer Center | |
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | NCT05638269 | Essential Hyper... Liver Cancer Nasopharyngeal ... Pancreatic Canc... Lung Cancer Chronic Kidney ... Acute Coronary ... Epilepsy Gastric Cancer Primary Aldoste... Subclinical hyp... | no intervention | 18 Years - 75 Years | Zhujiang Hospital | |
| A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors | NCT04476641 | Liver Cancer Kidney Cancer Nasopharyngeal ... Lung Cancer Colorectal Canc... Breast Cancer | CELL | 18 Years - 75 Years | Sun Yat-sen University | |
| 124I-FIAU Imaging in EBV and KSHV Associated Cancers | NCT00982449 | Hodgkin Lymphom... Non Hodgkin Lym... Kaposi's Sarcom... Gastric Cancer Nasopharyngeal ... | FIAU-PET-CT-2 FIAU-PET-CT-4 | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) | NCT00078546 | Nasopharyngeal ... EBV Infections | EBV specific CT... Anti CD45 monoc... | - | Baylor College of Medicine | |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | NCT00790569 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | nicotine varenicline placebo | 18 Years - 120 Years | Butler Hospital | |
| Bupropion in Helping Adults Stop Smoking | NCT00534001 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | bupropion hydro... placebo | 18 Years - 65 Years | Roswell Park Cancer Institute | |
| To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer | NCT00697619 | Nasopharyngeal ... | Zometa (zoledro... | 18 Years - 75 Years | Sun Yat-sen University | |
| 124I-FIAU Imaging in EBV and KSHV Associated Cancers | NCT00982449 | Hodgkin Lymphom... Non Hodgkin Lym... Kaposi's Sarcom... Gastric Cancer Nasopharyngeal ... | FIAU-PET-CT-2 FIAU-PET-CT-4 | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia | NCT02292368 | Head and Neck C... | Questionnaires Acupuncture Electroencephal... | 18 Years - | M.D. Anderson Cancer Center | |
| A Pilot Study of Acupuncture Treatment for Dysphagia | NCT00797732 | Carcinomas, Squ... Dysphagia | Acupuncture | 18 Years - | Dana-Farber Cancer Institute | |
| Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies | NCT04925544 | Nasopharyngeal ... Epstein-Barr Vi... | VK-2019 | 18 Years - | Stanford University | |
| Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure | NCT00530049 | Head and Neck C... Psychosocial Ef... | questionnaire a... assessment of t... psychosocial as... quality-of-life... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients | NCT02578641 | Nasopharyngeal ... | autologous EBV ... combination IV ... | 18 Years - | Tessa Therapeutics | |
| Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma | NCT03282617 | Nasopharyngeal ... | CD137L-DC-EBV-V... | 18 Years - 99 Years | National University Hospital, Singapore | |
| EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) | NCT00078546 | Nasopharyngeal ... EBV Infections | EBV specific CT... Anti CD45 monoc... | - | Baylor College of Medicine | |
| Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer | NCT01074021 | Nasopharyngeal ... | Nimotuzumab placebo plus ch... | 18 Years - 70 Years | Biotech Pharmaceutical Co., Ltd. | |
| A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer | NCT02608073 | Nasopharyngeal ... | Capecitabine Cisplatin | 18 Years - 75 Years | Hoffmann-La Roche | |
| A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy | NCT00370890 | Nasopharyngeal ... | Adjuvant chemot... | 18 Years - | Chinese University of Hong Kong | |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | NCT06019130 | Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Can... | Nivolumab Cisplatin 5-Fluorouracil Gemcitabine Radiotherapy Interferon beta... MRI PET Patient-Reporte... | 3 Years - | German Society for Pediatric Oncology and Hematology GPOH gGmbH | |
| Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer | NCT00656513 | Head and Neck C... Xerostomia | Pilocarpine ALTENS | 18 Years - | Radiation Therapy Oncology Group | |
| A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer | NCT02608073 | Nasopharyngeal ... | Capecitabine Cisplatin | 18 Years - 75 Years | Hoffmann-La Roche | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
